Analgesic use and change in kidney function in apparently healthy men - PubMed (original) (raw)
Multicenter Study
Analgesic use and change in kidney function in apparently healthy men
Tobias Kurth et al. Am J Kidney Dis. 2003 Aug.
Abstract
Background: Studies using a single creatinine measurement have yielded inconsistent results regarding analgesic use and kidney function.
Methods: This is a prospective cohort study of 4,494 US male physicians who provided blood samples in both 1982 and 1996. Outcomes measured were increase in plasma creatinine level of 0.3 mg/dL or greater (> or =26.5 micromol/L) and decline in glomerular filtration rate (GFR) of 29.0 mL/min/1.73 m2 or greater during this 14-year period. Self-reported use of aspirin, acetaminophen, and other nonsteroidal anti-inflammatory drugs (NSAIDs) was classified as never (<12 pills during the study period), 12 to 1,499 pills, 1,500 to 2,499 pills, and 2,500 or greater pills during the study period.
Results: Blood measurements made 14 years apart showed increased creatinine levels in 242 participants and decreased GFRs in 224 participants. Compared with never use, multivariable-adjusted odds ratios (ORs) of increased creatinine levels were 0.98 (95% confidence interval [CI], 0.43 to 2.23) for 2,500 or greater pills of aspirin, 1.02 (95% CI, 0.55 to 1.90) for 2,500 or greater pills of acetaminophen, and 1.12 (95% CI, 0.67 to 1.87) for 2,500 or greater pills of other NSAIDs. For decreased GFRs, ORs for intake of 2,500 or greater pills were 0.75 (95% CI, 0.35 to 1.57) for aspirin, 1.22 (95% CI, 0.66 to 2.26) for acetaminophen, and 1.11 (95% CI, 0.65 to 1.90) for other NSAIDs. Use of aspirin, but not acetaminophen or other NSAIDs, was associated with a reduced risk for change in kidney function in participants without cardiovascular risk factors and a possible but nonsignificant increase in those with cardiovascular risk factors.
Conclusion: Occasional to moderate analgesic intake of aspirin, acetaminophen, or NSAIDs does not appear to increase the risk for decline in kidney function during a period of 14 years.
Comment in
- Analgesics and renal disease in the postphenacetin era.
Schnuelle P, Van Der Woude FJ. Schnuelle P, et al. Am J Kidney Dis. 2003 Aug;42(2):385-7. doi: 10.1016/s0272-6386(03)00691-7. Am J Kidney Dis. 2003. PMID: 12900824 No abstract available.
Similar articles
- Analgesic use and renal function in men.
Rexrode KM, Buring JE, Glynn RJ, Stampfer MJ, Youngman LD, Gaziano JM. Rexrode KM, et al. JAMA. 2001 Jul 18;286(3):315-21. doi: 10.1001/jama.286.3.315. JAMA. 2001. PMID: 11466097 - Lifetime nonnarcotic analgesic use and decline in renal function in women.
Curhan GC, Knight EL, Rosner B, Hankinson SE, Stampfer MJ. Curhan GC, et al. Arch Intern Med. 2004 Jul 26;164(14):1519-24. doi: 10.1001/archinte.164.14.1519. Arch Intern Med. 2004. PMID: 15277282 - Association of analgesic use with prevalence of albuminuria and reduced GFR in US adults.
Agodoa LY, Francis ME, Eggers PW. Agodoa LY, et al. Am J Kidney Dis. 2008 Apr;51(4):573-83. doi: 10.1053/j.ajkd.2007.12.014. Epub 2008 Mar 3. Am J Kidney Dis. 2008. PMID: 18371533 - Nonsteroidal antiinflammatory drugs, acetaminophen, and hypertension.
Sudano I, Flammer AJ, Roas S, Enseleit F, Noll G, Ruschitzka F. Sudano I, et al. Curr Hypertens Rep. 2012 Aug;14(4):304-9. doi: 10.1007/s11906-012-0274-7. Curr Hypertens Rep. 2012. PMID: 22610476 Review. - Nonrenal toxicities of acetaminophen, aspirin, and nonsteroidal anti-inflammatory agents.
Matzke GR. Matzke GR. Am J Kidney Dis. 1996 Jul;28(1 Suppl 1):S63-70. doi: 10.1016/s0272-6386(96)90571-5. Am J Kidney Dis. 1996. PMID: 8669432 Review.
Cited by
- Pain Management in Pediatric Chronic Kidney Disease.
Reis A, Luecke C, Davis TK, Kakajiwala A. Reis A, et al. J Pediatr Pharmacol Ther. 2018 May-Jun;23(3):192-202. doi: 10.5863/1551-6776-23.3.192. J Pediatr Pharmacol Ther. 2018. PMID: 29970975 Free PMC article. Review. - Safe pharmacologic treatment strategies for osteoarthritis pain in African Americans with hypertension, and renal and cardiac disease.
Johnson J, Weinryb J. Johnson J, et al. J Natl Med Assoc. 2006 Jul;98(7):1126-35. J Natl Med Assoc. 2006. PMID: 16895283 Free PMC article. Review. - Prescribed Renoprotective Chinese Herbal Medicines Were Associated with a Lower Risk of All-Cause and Disease-Specific Mortality among Patients with Chronic Kidney Disease: A Population-Based Follow-Up Study in Taiwan.
Hsieh CF, Chang HC, Huang SL, Chen CL, Chen WT, Yang CC. Hsieh CF, et al. Evid Based Complement Alternat Med. 2017;2017:5632195. doi: 10.1155/2017/5632195. Epub 2017 Jul 17. Evid Based Complement Alternat Med. 2017. PMID: 28798802 Free PMC article. - Association of Non-Steroidal Anti-Inflammatory Drugs with Kidney Health in Ambulatory Older Adults.
Amatruda JG, Katz R, Peralta CA, Estrella MM, Sarathy H, Fried LF, Newman AB, Parikh CR, Ix JH, Sarnak MJ, Shlipak MG; Health ABC Study. Amatruda JG, et al. J Am Geriatr Soc. 2021 Mar;69(3):726-734. doi: 10.1111/jgs.16961. Epub 2020 Dec 10. J Am Geriatr Soc. 2021. PMID: 33305369 Free PMC article. - Channeling Bias in the Analysis of Risk of Myocardial Infarction, Stroke, Gastrointestinal Bleeding, and Acute Renal Failure with the Use of Paracetamol Compared with Ibuprofen.
Weinstein RB, Ryan PB, Berlin JA, Schuemie MJ, Swerdel J, Fife D. Weinstein RB, et al. Drug Saf. 2020 Sep;43(9):927-942. doi: 10.1007/s40264-020-00950-3. Drug Saf. 2020. PMID: 32500272 Free PMC article.